Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Actual shortage | 2023-06-19 | 2024-05-09 | 195478 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Actual shortage | 2024-03-07 | 2024-05-09 | 221534 |
| TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-18 | 2024-05-09 | 222572 |
| TEVA-CLOPIDOGREL | 300MG | TABLET | Actual shortage | 2023-12-07 | 2024-05-09 | 212720 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-04-27 | 2024-05-09 | 190785 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-28 | 2024-05-09 | 223856 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-05 | 2024-05-09 | 224445 |
| TEVA-EZETIMIBE | 10MG | TABLET | Actual shortage | 2024-03-18 | 2024-05-09 | 222569 |
| TEVA-EZETIMIBE | 10MG | TABLET | Actual shortage | 2024-03-28 | 2024-05-09 | 223850 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Actual shortage | 2023-10-19 | 2024-05-09 | 207518 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Actual shortage | 2023-07-11 | 2024-05-09 | 198306 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Actual shortage | 2023-08-17 | 2024-05-09 | 202252 |
| TEVA-TOPIRAMATE | 25MG | TABLET | Actual shortage | 2024-04-11 | 2024-05-09 | 224889 |
| TEVA-NITROFURANTOIN | 100MG | CAPSULE | Actual shortage | 2024-02-15 | 2024-05-09 | 219677 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Actual shortage | 2023-10-19 | 2024-05-09 | 207512 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Actual shortage | 2024-02-22 | 2024-05-09 | 220261 |
| TEVA-DOXYCYCLINE | 100MG | TABLET | Actual shortage | 2024-04-18 | 2024-05-09 | 225483 |
| TEVA-DOMPERIDONE | 10MG | TABLET | Actual shortage | 2024-02-29 | 2024-05-09 | 220980 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Actual shortage | 2024-02-29 | 2024-05-09 | 220977 |
| TEVA-ATOMOXETINE | 25MG | CAPSULE | Actual shortage | 2024-04-05 | 2024-05-03 | 224451 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |